drugset / Trial / NCT02380755

Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism

NCT02380755

RandomizedParallel-groupTriple-blindTreatment

Summary

Hypogonadism is a clinical condition that can be associated with obesity in man. Controversy exists regarding if its a condition that needs to be treated. The standard Testosterone Therapy is associated with increase in cardiovascular risks, according to some studies, and leads to infertility. The use of Clomiphene Citrate in this sub population of obese man as an alternative treatment option is not well studied. The aim of this protocol is to evaluate the cardiovascular risks, metabolic and hormonal parameters in a double blinded randomized placebo trial.

Timeline

Start
2015-04
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clomiphene Other / unclassified 50 mg Oral